4th ADC Analytical Development Summit

The 4th ADC Analytical Development Summit focuses on refining analytical techniques to meet the increasing regulatory demands and product complexity in ADC development.

Download the official brochure here: https://ter.li/9upyt5

With regulatory expectations tightening, this summit offers actionable insights to enhance methodologies through in-depth discussions and case studies. Topics include optimizing DAR quantification, improving aggregation analysis, and refining impurity profiling. Leave with best practices to ensure ADC product quality and navigate regulatory challenges.

Join leading experts in the field to address the unique analytical challenges of antibody-drug conjugates. Speakers include:

Carrie Sowers, Associate Director, Physicochemical Development, AstraZeneca
Kevin Halloran, Senior Scientist, AbbVie
Khyati Shah, Associate Director, Sutro Biopharma
Meghan O'Leary, Senior Scientist, Merck
Sreya Sarkar, Senior Scientist, Genentech
Yuan Gao, Head, ADC Development, ADC Therapeutics